Tg Therapeutics TGTX
NASDAQ TGTX
$53.06 -0.14 (-0.26%)
As of: Oct 22, 2026 · 10:50 AM EDT

Tg Therapeutics (TGTX) Long-Term Debt Repayments (2014)

Updated

Tg Therapeutics' Long-Term Debt Repayments was $677,778 in FY2014.

Analysis

Tg Therapeutics (TGTX) Long-Term Debt Repayments (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,166.78 Bn 1,135.37 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 635.34 Bn 553.86 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.48 Bn 476.60 Bn 12.70 Bn 2.00 Bn
4 Merck 377.08 Bn 331.46 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 304.13 Bn 268.12 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 267.48 Bn 241.16 Bn 12.86 Bn 2.46 Bn
7 Amgen 241.75 Bn 197.15 Bn 7.24 Bn -
8 Gilead Sciences 194.09 Bn 168.29 Bn 6.22 Bn 17.00 Mn
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn -
10 Tg Therapeutics 7.52 Bn 6.91 Bn 199.14 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 677,778.00
API Access

Tg Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=TGTX&period=max&api_key=YOUR_API_KEY